Recap: Enanta Pharma Q4 Earnings

Loading...
Loading...

Enanta Pharma ENTA reported its Q4 earnings results on Monday, November 20, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Enanta Pharma beat estimated earnings by 33.5%, reporting an EPS of $-1.33 versus an estimate of $-2.0.

Revenue was down $1.39 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.47 which was followed by a 4.24% drop in the share price the next day.

Here's a look at Enanta Pharma's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -2.33 -1.98 -1.59 -1.35
EPS Actual -1.86 -1.79 -1.39 -1.27
Revenue Estimate 18.06M 19.18M 22.57M 22.86M
Revenue Actual 18.89M 17.80M 23.59M 20.32M

To track all earnings releases for Enanta Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...